1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-28 of 28 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikisEvdokiou, A.; Labrinidis, A.; Bouralexis, S.; Hay, S.; Findlay, D.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2009Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse modelLabrinidis, A.; Hay, S.; Liapis, V.; Ponomarev, V.; Findlay, D.; Evdokiou, A.
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.
2000Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptorRaggatt, L.; Evdokiou, A.; Findlay, D.
2000Identification of a novel calcitonin-response element in the promoter of the human p21 WAF1/CIP1 geneEvdokiou, A.; Raggatt, L.; Sakai, T.; Findlay, D.

Discover